These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9360663)

  • 41. Summary of: the development of a concise questionnaire designed to measure perceived outcomes on the issues of greatest importance to patients.
    Richards W
    Br Dent J; 2012 Apr; 212(8):382-3. PubMed ID: 22538902
    [No Abstract]   [Full Text] [Related]  

  • 42. Changes in quality of life (QoL) and other patient-reported outcome measures (PROMs) in living-donor and deceased-donor kidney transplant recipients and those awaiting transplantation in the UK ATTOM programme: a longitudinal cohort questionnaire survey with additional qualitative interviews.
    Gibbons A; Bayfield J; Cinnirella M; Draper H; Johnson RJ; Oniscu GC; Ravanan R; Tomson C; Roderick P; Metcalfe W; Forsythe JLR; Dudley C; Watson CJE; Bradley JA; Bradley C
    BMJ Open; 2021 Apr; 11(4):e047263. PubMed ID: 33853805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-Reported Outcome Measures for Adults With Kidney Disease: Current Measures, Ongoing Initiatives, and Future Opportunities for Incorporation Into Patient-Centered Kidney Care.
    Nair D; Wilson FP
    Am J Kidney Dis; 2019 Dec; 74(6):791-802. PubMed ID: 31492487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psychometric validation of three new condition-specific questionnaires to assess quality of life, symptoms and treatment satisfaction of patients with aortic aneurysm.
    Romaine J; Peach G; Thompson M; Hinchliffe RJ; Bradley C
    J Patient Rep Outcomes; 2019 May; 3(1):29. PubMed ID: 31098754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-Reported Outcomes in Patients with Chronic Kidney Disease and Kidney Transplant-Part 1.
    Tang E; Bansal A; Novak M; Mucsi I
    Front Med (Lausanne); 2017; 4():254. PubMed ID: 29379784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient preferences, knowledge and beliefs about kidney allocation: qualitative findings from the UK-wide ATTOM programme.
    Gibbons A; Cinnirella M; Bayfield J; Wu D; Draper H; Johnson RJ; Tomson CR; Forsythe JL; Metcalfe W; Fogarty D; Roderick P; Ravanan R; Oniscu GC; Watson CJ; Bradley JA; Bradley C
    BMJ Open; 2017 Jan; 7(1):e013896. PubMed ID: 28132010
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis.
    Oniscu GC; Ravanan R; Wu D; Gibbons A; Li B; Tomson C; Forsythe JL; Bradley C; Cairns J; Dudley C; Watson CJ; Bolton EM; Draper H; Robb M; Bradbury L; Pruthi R; Metcalfe W; Fogarty D; Roderick P; Bradley JA;
    BMJ Open; 2016 Feb; 6(2):e010377. PubMed ID: 26916695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of simultaneous pancreas-kidney transplantation: patients' perspectives.
    Isla Pera P; Moncho Vasallo J; Guasch Andreu O; Ricart Brulles M; Torras Rabasa A
    Patient Prefer Adherence; 2012; 6():597-603. PubMed ID: 22936846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feedback on the FDA's February 2006 draft guidance on Patient Reported Outcome (PRO) measures from a developer of PRO measures.
    Bradley C
    Health Qual Life Outcomes; 2006 Oct; 4():78. PubMed ID: 17029628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL).
    Mitchell J; Bradley C
    Qual Life Res; 2004 Aug; 13(6):1163-75. PubMed ID: 15287282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Review of quality of life instruments used in end-stage renal disease].
    Gentile S; Delarozière JCh; Fernandez C; Tardieu S; Devictor B; Dussol B; Daurès JP; Berland Y; Sambuc R
    Nephrologie; 2003; 24(6):293-301. PubMed ID: 14584296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of a renal-dependent individualized quality of life questionnaire.
    Bradley C
    Adv Perit Dial; 1997; 13():116-20. PubMed ID: 9360663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of clinical and individual variables on quality of life in chronic renal failure patients.
    Baiardi F; Degli Esposti E; Cocchi R; Fabbri A; Sturani A; Valpiani G; Fusarol M
    J Nephrol; 2002; 15(1):61-7. PubMed ID: 11936428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
    Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Measuring quality of life in end-stage renal disease. Transcultural adaptation and validation of the specific Kidney Disease Quality of Life questionnaire].
    Boini S; Leplege A; Loos Ayav C; Français P; Ecosse E; Briançon S
    Nephrol Ther; 2007 Oct; 3(6):372-83. PubMed ID: 17919640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure.
    Barendse SM; Speight J; Bradley C
    Am J Kidney Dis; 2005 Mar; 45(3):572-9. PubMed ID: 15754280
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.